Does NIVOLUMAB Cause Erythema multiforme? 221 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 221 reports of Erythema multiforme have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.3% of all adverse event reports for NIVOLUMAB.
221
Reports of Erythema multiforme with NIVOLUMAB
0.3%
of all NIVOLUMAB reports
31
Deaths
132
Hospitalizations
How Dangerous Is Erythema multiforme From NIVOLUMAB?
Of the 221 reports, 31 (14.0%) resulted in death, 132 (59.7%) required hospitalization, and 27 (12.2%) were considered life-threatening.
Is Erythema multiforme Listed in the Official Label?
Yes, Erythema multiforme is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Erythema multiforme?
IBUPROFEN (226)
PEMBROLIZUMAB (212)
LAMOTRIGINE (210)
ACETAMINOPHEN (172)
PACLITAXEL (166)
AMOXICILLIN (164)
ALLOPURINOL (147)
CARBOPLATIN (146)
CLARITHROMYCIN (131)
SULFAMETHOXAZOLE\TRIMETHOPRIM (130)
Which NIVOLUMAB Alternatives Have Lower Erythema multiforme Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE